In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether we can purify and grow a
population of cells from the participants blood (iNKT cells) and then safely give them back
to the participant in increased numbers, and whether these cells will then stimulate the
bodies own immune response against the cancer. These iNKT cells have been used in laboratory
studies and information from these and other research studies suggest that increasing the
number of these cells in the blood can stimulate the immune response against tumors.